Summary:
- A melanoma vaccine has been found to reduce the risk of cancer recurrence or death by 49% over three years.
- Researchers have discovered promising results in reducing the risk of redeveloping melanoma.
- The vaccine shows significant potential in improving outcomes for melanoma patients.
- This breakthrough could lead to new avenues in cancer treatment.
